Anti-viral properties of antipsychotic medications in the time of COVID-19

Psychiatry Res. 2021 Jan:295:113626. doi: 10.1016/j.psychres.2020.113626. Epub 2020 Nov 30.

Authors

Ragy R Girgis¹, Jeffrey A Lieberman²

Affiliations

¹ Department of Psychiatry, College of Physicians and Surgeons, Columbia University, and New York State Psychiatric Institute, 1051 Riverside Drive, Unit 31, New York, NY 10032, United States. Electronic address: ragy.girgis@nyspi.columbia.edu.
² Department of Psychiatry, College of Physicians and Surgeons, Columbia University, and New York State Psychiatric Institute, 1051 Riverside Drive, Unit 31, New York, NY 10032, United States.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antipsychotic Agents*
Antiviral Agents* / therapeutic use
COVID-19*
Drug Repositioning
Humans
Protein Interaction Maps
SARS-CoV-2

Substances

Antipsychotic Agents
Antiviral Agents